(1)要約四半期連結財政状態計算書

(単位:百万円)

 

 

前連結会計年度
(2025年3月31日)

 

当第3四半期連結会計期間
(2025年12月31日)

資産

 

 

 

 

流動資産

 

 

 

 

現金及び現金同等物

 

209,838

 

214,768

営業債権及びその他の債権

 

593,836

 

604,637

その他の金融資産

 

45,015

 

62,115

棚卸資産

 

625,243

 

661,400

その他の流動資産

 

49,993

 

57,872

小計

 

1,523,925

 

1,600,792

売却目的で保有する資産

 

59,209

 

流動資産合計

 

1,583,134

 

1,600,792

非流動資産

 

 

 

 

有形固定資産

 

759,266

 

773,384

のれん

 

257,811

 

270,092

無形資産

 

239,319

 

228,279

持分法で会計処理されている
投資

 

287,977

 

200,345

その他の金融資産

 

177,405

 

296,252

退職給付に係る資産

 

72,618

 

74,517

繰延税金資産

 

34,608

 

37,931

その他の非流動資産

 

27,646

 

28,834

非流動資産合計

 

1,856,650

 

1,909,634

資産合計

 

3,439,784

 

3,510,426

 

 

 

 

 

 

 

 

(単位:百万円)

 

 

前連結会計年度
(2025年3月31日)

 

当第3四半期連結会計期間
(2025年12月31日)

負債及び資本

 

 

 

 

負債

 

 

 

 

流動負債

 

 

 

 

社債及び借入金

 

252,892

 

256,022

営業債務及びその他の債務

 

488,132

 

473,589

その他の金融負債

 

81,364

 

60,535

未払法人所得税等

 

10,627

 

8,785

引当金

 

89,711

 

102,724

その他の流動負債

 

109,360

 

118,247

小計

 

1,032,086

 

1,019,902

売却目的で保有する資産に
直接関連する負債

 

6,661

 

流動負債合計

 

1,038,747

 

1,019,902

非流動負債

 

 

 

 

社債及び借入金

 

1,033,236

 

965,463

その他の金融負債

 

91,157

 

88,566

退職給付に係る負債

 

24,841

 

23,781

引当金

 

25,974

 

26,033

繰延税金負債

 

111,048

 

93,170

その他の非流動負債

 

40,366

 

27,358

非流動負債合計

 

1,326,622

 

1,224,371

負債合計

 

2,365,369

 

2,244,273

資本

 

 

 

 

資本金

 

90,059

 

90,179

資本剰余金

 

 

117

利益剰余金

 

640,611

 

697,783

自己株式

 

8,361

 

8,364

その他の資本の構成要素

 

174,871

 

250,203

売却目的で保有する資産に関連する
その他の包括利益

 

3,610

 

親会社の所有者に帰属する持分
合計

 

900,790

 

1,029,918

非支配持分

 

173,625

 

236,235

資本合計

 

1,074,415

 

1,266,153

負債及び資本合計

 

3,439,784

 

3,510,426

 

 

 

 

 

 

 

E00752 40050 住友化学株式会社 SUMITOMO CHEMICAL COMPANY, LIMITED 四半期第3号参考様式 [IFRS](連結) IFRS true cte 2025-04-01 2025-12-31 Q3 2026-03-31 2024-04-01 2024-12-31 2025-03-31 1 false false false 40050 2026-02-03 40050 2025-12-31 40050 2025-12-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2025-12-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2025-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2025-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2025-12-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2025-12-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2025-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2025-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2025-12-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2025-12-31 jpigp_cor:ShareCapitalIFRSMember 40050 2025-12-31 jpigp_cor:TreasurySharesIFRSMember 40050 2025-12-31 tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2025-04-01 2025-12-31 40050 2025-04-01 2025-12-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2025-04-01 2025-12-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2025-04-01 2025-12-31 jpcrp_cor:EntityTotalMember 40050 2025-04-01 2025-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2025-04-01 2025-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2025-04-01 2025-12-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2025-04-01 2025-12-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2025-04-01 2025-12-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 40050 2025-04-01 2025-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2025-04-01 2025-12-31 jpcrp_cor:ReconcilingItemsMember 40050 2025-04-01 2025-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2025-04-01 2025-12-31 jpcrp_cor:ReportableSegmentsMember 40050 2025-04-01 2025-12-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2025-04-01 2025-12-31 jpigp_cor:ShareCapitalIFRSMember 40050 2025-04-01 2025-12-31 jpigp_cor:TreasurySharesIFRSMember 40050 2025-04-01 2025-12-31 tse-qcediffr-40050:AdvancedMedicalSolutionsReportableSegmentMember 40050 2025-04-01 2025-12-31 tse-qcediffr-40050:AgroAndLifeSolutionsReportableSegmentMember 40050 2025-04-01 2025-12-31 tse-qcediffr-40050:EssentialAndGreenMaterialsReportableSegmentMember 40050 2025-04-01 2025-12-31 tse-qcediffr-40050:ICTAndMobilitySolutionsReportableSegmentMember 40050 2025-04-01 2025-12-31 tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2025-04-01 2025-12-31 tse-qcediffr-40050:SumitomoPharmaReportableSegmentMember 40050 2024-12-31 40050 2024-12-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2024-12-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2024-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2024-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2024-12-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2024-12-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2024-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2024-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2024-12-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2024-12-31 jpigp_cor:ShareCapitalIFRSMember 40050 2024-12-31 jpigp_cor:TreasurySharesIFRSMember 40050 2024-12-31 tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2025-03-31 40050 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2025-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2025-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2025-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2025-03-31 tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2024-04-01 2024-12-31 40050 2024-04-01 2024-12-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2024-04-01 2024-12-31 jpcrp_cor:EntityTotalMember 40050 2024-04-01 2024-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2024-04-01 2024-12-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 40050 2024-04-01 2024-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2024-04-01 2024-12-31 jpcrp_cor:ReconcilingItemsMember 40050 2024-04-01 2024-12-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2024-04-01 2024-12-31 jpcrp_cor:ReportableSegmentsMember 40050 2024-04-01 2024-12-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:ShareCapitalIFRSMember 40050 2024-04-01 2024-12-31 jpigp_cor:TreasurySharesIFRSMember 40050 2024-04-01 2024-12-31 tse-qcediffr-40050:AdvancedMedicalSolutionsReportableSegmentMember 40050 2024-04-01 2024-12-31 tse-qcediffr-40050:AgroAndLifeSolutionsReportableSegmentMember 40050 2024-04-01 2024-12-31 tse-qcediffr-40050:EssentialAndGreenMaterialsReportableSegmentMember 40050 2024-04-01 2024-12-31 tse-qcediffr-40050:ICTAndMobilitySolutionsReportableSegmentMember 40050 2024-04-01 2024-12-31 tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2024-04-01 2024-12-31 tse-qcediffr-40050:SumitomoPharmaReportableSegmentMember 40050 2024-03-31 40050 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2024-03-31 tse-qcediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure